Inmunidad Colectiva Conductual en Sarampión: del Umbral Biológico a la Acción Colectiva desde el Modelo Cognitivo-Conductual y la Psicología Positiva
Resumen
Introducción: El sarampión, por su extrema transmisibilidad, funciona como evento centinela que revela fallas acopladas de cobertura efectiva, equidad subnacional y velocidad de respuesta. Proponemos un giro epistémico: la inmunidad colectiva conductual (ICC) como propiedad emergente de los sistemas sociosanitarios y comunitarios, determinada por la adopción, repetición y coordinación de conductas protectoras que permiten que la inmunidad biológica se traduzca en protección poblacional y respuesta oportuna (48–72 h), desde el Modelo Cognitivo-Conductual (MCC) y la Psicología Positiva(PP). Objetivo: Formular un marco comprensivo y replicable para México y América Latina que operacionalice la ICC y traduzca determinantes conductuales en acciones verificables, integrando MCC y la PP como fundamento de acción colectiva medible. Métodos: Revisión narrativa trazable orientada a implementación (2018–2026), integrando evidencia epidemiológica e institucional con marcos de ciencias del comportamiento (BeSD/5C), especificación de estrategias (ERIC) y evaluación mínima de implementación e impacto poblacional (Proctor y RE-AIM). Resultados: Se identifican perfiles de fricción cognitivos, normativos y prácticos que explican bolsas subvacunadas y respuestas tardías. Se propone un paquete mínimo replicable por escenarios (rezagos, brote focal y transmisión multiterritorial) y un tablero trazador mínimo que vincula diagnóstico conductual, intervención y verificación mediante adopción, fidelidad, penetración y sostenibilidad. Conclusiones: La ICC permite pasar del umbral biológico a la acción colectiva medible. Aunque el sarampión es un caso paradigmático, el marco es transferible a otras infecciones de alta expresión poblacional donde la cooperación sostenida y la gobernanza conductual determinan el control.
Descargas
Citas
Baethge, C., Goldbeck-Wood, S., & Mertens, S. (2019). SANRA—a scale for the quality assessment of narrative review articles. Research Integrity and Peer Review, 4, 5. https://doi.org/10.1186/s41073-019-0064-8
Betsch, C., Schmid, P., Heinemeier, D., Korn, L., Holtmann, C., & Böhm, R. (2018). Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE, 13(12), e0208601. https://doi.org/10.1371/journal.pone.0208601
Böhm, R., Meier, N. W., Groß, M., Korn, L., & Betsch, C. (2019). The willingness to vaccinate increases when vaccination protects others who have low responsibility for not being vaccinated. Journal of Behavioral Medicine, 42, 381–391. https://doi.org/10.1007/s10865-018-9985-9
Brewer, N. T., Chapman, G. B., Rothman, A. J., Leask, J., & Kempe, A. (2017). Increasing vaccination: Putting psychological science into action. Psychological Science in the Public Interest, 18(3), 149–207. https://doi.org/10.1177/1529100618760521
Calleja, N., AbdAllah, A., Abad, N., Ahmed, N., Albarracin, D., Altieri, E., Anoko, J. N., Arcos, R., Azlan, A. S., Bayer, J., Bengtsson, L., Bekli, M., Boateng, K. J., Bruns, A., Czerniak, C., De Domenico, M., Dormans, L., Garcia-Saisó, S., Ghenaiat, S., Wilkins, N. (2021). A public health research agenda for managing infodemics: Methods and results of the first WHO infodemiology conference. JMIR Infodemiology, 1(1), e30979. https://doi.org/10.2196/30979
Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation Science, 4, 50. https://doi.org/10.1186/1748-5908-4-50
Dempsey, R. C., & Wood, A. (2025). Behavioural science and public health action. Current Directions in Psychological Science. Advance online publication. https://doi.org/10.1177/09637214251340023
Do, L. A. H., & Mulholland, K. (2025). Measles. The New England Journal of Medicine, 393, 2447–2458. https://doi.org/10.1056/NEJMra2504516
Fredrickson, B. L. (2001). The role of positive emotions in positive psychology: The broaden-and-build theory of positive emotions. American Psychologist, 56(3), 218–226. https://doi.org/10.1037/0003-066X.56.3.218
Gagneur, A. (2020). Motivational interviewing: A powerful tool to address vaccine hesitancy. Canada Communicable Disease Report, 46(4), 93–97. https://doi.org/10.14745/ccdr.v46i04a06
Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999). Evaluating the public health impact of health promotion interventions: The RE-AIM framework. American Journal of Public Health, 89(9), 1322–1327. https://doi.org/10.2105/AJPH.89.9.1322
Malik, A. A., Ahmed, N., Shafiq, M., et al. (2023). Vaccine hesitancy and health policy implications. Health Policy, 137, 104894. https://doi.org/10.1016/j.healthpol.2023.104894
Mina, M. J., Kula, T., Leng, Y., Choi, M., Singh, T., Schwerk, N., Henning, S. J., Wesselhoeft, J. L., Shrock, E. L., Tokuyama, M., Pan, Q., Klimstra, W. B., Rimmelzwaan, G. F., Roels, S., de Swart, R. L., & Elledge, S. J. (2019). Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science, 366(6465), 599–606. https://doi.org/10.1126/science.aay6485
Minta, A. A., Ferrari, M., Antoni, S., Portnoy, A., Sbarra, A., Lambert, B., Haurani, M., Ho, L. L., Steulet, C., Rota, P. A., Mulders, M. N., Gacic-Dobo, M., Kretsinger, K., & Crowcroft, N. S. (2024). Progress toward measles elimination — Worldwide, 2000–2023. MMWR Morbidity and Mortality Weekly Report, 73(45), 1036–1042. https://doi.org/10.15585/mmwr.mm7345a4
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Pan American Health Organization. (2016, September 27). Region of the Americas is declared free of measles. https://www.paho.org/en/news/27-9-2016-region-americas-declared-free-measles
Pan American Health Organization. (2025a, July 1). Epidemiological update: Measles in the Americas region – 1 July 2025. https://www.paho.org/en/documents/epidemiological-update-measles-americas-region-1-july-2025
Pan American Health Organization. (2025b, July 3). Measles cases rise in the Americas in 2025. https://www.paho.org/en/news/3-7-2025-measles-cases-rise-americas-2025
Pan American Health Organization. (n.d.). Measles and Rubella Risk Assessment Tool — User Guide / Workbook. https://iris.paho.org/items/c6a5db73-9004-4e3e-8de2-ea25dcb7b975
Patel, M. S., Winegar, A., Fogel, J., et al. (2022). Effect of text message reminders and vaccine reservations on adherence to a health system COVID-19 vaccination policy: A randomized clinical trial. JAMA Network Open, 5(7), e2222116. https://doi.org/10.1001/jamanetworkopen.2022.22116
Powell, B. J., Waltz, T. J., Chinman, M. J., et al. (2015). A refined compilation of implementation strategies: Results from the ERIC project. Implementation Science, 10, 21. https://doi.org/10.1186/s13012-015-0209-1
Proctor, E. K., Silmere, H., Raghavan, R., et al. (2011). Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health, 38(2), 65–76. https://doi.org/10.1007/s10488-010-0319-7
Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., et al. (2021). PRISMA-S: An extension to the PRISMA statement for reporting literature searches in systematic reviews. Systematic Reviews, 10(1), 39. https://doi.org/10.1186/s13643-020-01542-z
Secretaría de Salud. (2019). Lineamientos para la vigilancia por laboratorio de las enfermedades febriles exantemáticas (EFE). Gobierno de México. https://www.gob.mx/cms/uploads/attachment/file/487585/LVL_EFE_4T.pdf
Secretaría de Salud. (2025a). Informe diario del brote de sarampión en México, 2025. Gobierno de México. https://www.gob.mx/salud/documentos/informe-diario-del-brote-de-sarampion-en-mexico-2025
Secretaría de Salud. (2025b). Plan de respuesta rápida para la prevención y control del sarampión, rubéola y SRC (Edición 2025). Gobierno de México. https://www.gob.mx/cms/uploads/attachment/file/1014168/Docto-RR-Sarampion-22jul25.pdf
Su, Y., Zhang, X., & Zhang, S. (2023). Vaccine uptake and collective action. Human Vaccines & Immunotherapeutics, 19(2), 2256041. https://doi.org/10.1080/21645515.2023.2256041
Van der Linden, S., & Roozenbeek, J. (2024). Inoculation to resist misinformation. JAMA, 331(22), 1961–1962. https://doi.org/10.1001/jama.2024.5026
World Health Organization. (2018). Manual for the laboratory-based surveillance of measles, rubella and congenital rubella syndrome (3rd ed.). https://www.who.int/teams/immunization-vaccines-and-biologicals/immunization-analysis-and-insights/surveillance/surveillance-for-vpds/laboratory-networks/measles-and-rubella-laboratory-network/manual-for-the-laboratory-based-surveillance-of-measles-rubella-and-congenital-rubella-syndrome
World Health Organization. (2020). Immunization Agenda 2030: A global strategy to leave no one behind. https://www.who.int/publications/m/item/immunization-agenda-2030-a-global-strategy-to-leave-no-one-behind
World Health Organization. (2021). WHO public health research agenda for managing infodemics. https://www.who.int/publications/i/item/9789240019508
World Health Organization. (2022a). Behavioural and social drivers of vaccination: Tools and practical guidance for achieving high uptake. https://www.who.int/publications/i/item/9789240049680
World Health Organization. (2022b). Understanding the behavioural and social drivers of vaccine uptake: WHO position paper. Weekly Epidemiological Record, 97(20), 209–224. https://www.who.int/publications/i/item/who-wer9720-209-224
World Health Organization. (2025a, November 28). Measles deaths down 88% since 2000, but cases surge [News release]. https://www.who.int/news/item/28-11-2025-measles-deaths-down-88--since-2000--but-cases-surge
World Health Organization. (2025b). IA2030 – SP 3.2 High and equitable coverage: DTP3, MCV1, and MCV2 coverage in the 20% of districts with lowest coverage (Indicator Metadata Registry). https://www.who.int/data/gho/indicator-metadata-registry/imr-details/7770
Derechos de autor 2026 Mauricio Fidel Mendoza González , Carolina Delgado Domínguez, Manuel Salvador Luzanía Valerio
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.png)
.png)
1.png)
